Tectonic Therapeutics TECX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -37.8%— | —— | —— | —— | |
| Return on assets | -35.8%+24.5pp | -60.3%-0.6pp | -59.7%+9.1pp | -68.8%-18.7pp | |
| Liquidity | |||||
| Current ratio | 26.6×+14.0× | 12.6×+11.9× | 0.8×-6.9× | 7.6×-2.7× | |
| Quick ratio | 26.6×+14.0× | 12.6×+11.9× | 0.8×-6.9× | 7.6×-2.7× | |
| Cash ratio | 26.3×+14.0× | 12.2×+11.5× | 0.7×-2.1× | 2.8×-7.0× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×— | —— | —— | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0.1×-0.1× | 0.2×+0.1× | |
| Interest coverage | -1,333.9×-787× | -547.3×-183× | -364.1×— | —— | |
| Per Share | |||||
| Book value per share | $13.72-17.3% | $16.58+125% | -$66.72-6,292% | -$1.04-126% | |
| Valuation | |||||
| Market capitalization | $585.51M+58.3% | $681.13M— | —— | —— | |
| Enterprise value | $353.51M+438% | $543.1M— | —— | —— | |
| Price / book | 2.5×+1.3× | 4.8×— | —— | —— | |
| Free cash flow yield | -11.2%+5.8pp | -8.7%— | —— | —— | |
| Earnings yield | -14.3%+1.6pp | -8.5%— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Tectonic Therapeutics's ratios come from?
- Every ratio is computed from Tectonic Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.